Arkolith/Insider Trading/RPHM/Form 4

O'Donnell Niall

DirectorReneo Pharmaceuticals, Inc. (RPHM) · full profile →Form 4 · filed May 10, 2023
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2023Buy(P)125K$8.00$1.0M2.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-028533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML